SC
BMY icon

Skylands Capital’s Bristol-Myers Squibb BMY Stock Holding History

Skylands Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.99M Sell
138,725
-2,675
-2% -$154K 0.98% 34
2026
Q1 		$8.58M Sell
141,400
-1,080
-0.8% -$63K 1.12% 28
2025
Q4 		$7.6M Sell
142,480
-18,400
-11% -$885K 1.03% 30
2025
Q3 		$7.26M Sell
160,880
-5,485
-3% -$256K 1% 31
2025
Q2 		$7.7M Buy
166,365
+23,915
+17% +$1.17M 1.12% 26
2025
Q1 		$8.69M Sell
142,450
-21,225
-13% -$1.24M 1.25% 23
2024
Q4 		$9.26M Sell
163,675
-17,400
-10% -$972K 1.29% 22
2024
Q3 		$9.37M Sell
181,075
-39,725
-18% -$1.86M 1.27% 19
2024
Q2 		$9.17M Buy
220,800
+32,150
+17% +$1.44M 1.3% 21
2024
Q1 		$10.2M Buy
188,650
+9,625
+5% +$490K 1.41% 19
2023
Q4 		$9.19M Sell
179,025
-17,875
-9% -$938K 1.35% 18
2023
Q3 		$11.4M Buy
196,900
+14,850
+8% +$910K 1.73% 12
2023
Q2 		$11.6M Sell
182,050
-4,975
-3% -$334K 1.67% 13
2023
Q1 		$13M Buy
187,025
+71,800
+62% +$5.06M 1.9% 12
2022
Q4 		$8.29M Sell
115,225
-11,275
-9% -$850K 1.31% 20
2022
Q3 		$8.99M Sell
126,500
-4,400
-3% -$319K 1.48% 15
2022
Q2 		$10.1M Sell
130,900
-36,620
-22% -$2.79M 1.48% 18
2022
Q1 		$12.2M Sell
167,520
-32,025
-16% -$2.15M 1.48% 17
2021
Q4 		$12.4M Buy
199,545
+16,825
+9% +$987K 1.44% 17
2021
Q3 		$10.8M Sell
182,720
-19,500
-10% -$1.28M 1.34% 19
2021
Q2 		$13.4M Sell
202,220
-11,400
-5% -$743K 1.59% 15
2021
Q1 		$13.5M Buy
213,620
+23,810
+13% +$1.48M 1.72% 16
2020
Q4 		$11.8M Buy
189,810
+29,550
+18% +$1.82M 1.71% 18
2020
Q3 		$9.59M Buy
160,260
+14,800
+10% +$891K 1.6% 17
2020
Q2 		$8.55M Buy
145,460
+103,470
+246% +$6.19M 1.51% 16
2020
Q1 		$2.34M Sell
41,990
-250
-0.6% -$15.3K 0.52% 44
2019
Q4 		$2.69M Buy
+42,240
New +$2.42M 0.39% 55

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Skylands Capital's BMY Position: Q2 2026 in Review

Skylands Capital reduced its Bristol-Myers Squibb (BMY) stake by 1.9% in Q2 2026, selling an estimated $154K and leaving 138,725 shares worth $7.99M. The position accounts for 0.98% of the portfolio, ranked #34.

Skylands Capital first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $13.5M in Q1 2021. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Skylands Capital held 138,725 shares of Bristol-Myers Squibb worth $7.99M as of Q2 2026.
  • Skylands Capital sold 2,675 Bristol-Myers Squibb shares in Q2 2026, an estimated $154K.
  • Bristol-Myers Squibb made up 0.98% of Skylands Capital's portfolio in Q2 2026, its #34 holding.
  • Skylands Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
  • Skylands Capital's Bristol-Myers Squibb position peaked at $13.5M in Q1 2021.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Skylands Capital's 13F filing for Q2 2026, filed 24 Jul 2026.